View Cart (0 items)
Pharmaceutical

Johnson & Johnson Executives Briefed on Motrin “Recall”

June 15, 2010
/ Print / Reprints /
| Share More
/ Text Size+
The Associated Press reports that Johnson & Johnson executives were briefed on an outside contractor''s plan to buy up defective painkillers instead of issuing a recall, documents obtained by The Associated Press on Friday indicate. E-mails sent to J&J last spring by contractor Inmar show the company was informed that the plan to purchase thousands of packets of Motrin could "draw scrutiny," in the words one Inmar executive. Congressional investigators have been probing J&J''s handling of problems with its Motrin tablets that emerged last year. The maker of consumer products and medicines has attracted scrutiny after a slew of product recalls, most recently involving dozens of children''s medicines. The communication between J&J and Inmar, a supply-chain management company, appears to contradict testimony from J&J executive Colleen Goggins, who told lawmakers last month that J&J was not aware of the plan to use contractors posing as customers to buy the defective product. But a memo signed by J&J''s McNeil Consumer Healthcare unit instructs Inmar employees to "not communicate to store personnel any information about this product. Simply visit each store, locate the product and, if any is found, purchase all of the product."
You must login or register in order to post a comment.